Stock Events

VanEck Biotech 

CL$163.65
17
+CL$0+0% Friday 15:46

Statistics

Day High
0
Day Low
0
52W High
163.65
52W Low
0
Volume
0
Avg. Volume
0
Mkt Cap
-
P/E Ratio
-
Dividend Yield
406.64%
Dividend
665.46

Upcoming

23
DEC
Dividend Ex
23
DEC
Dividend Payment
19
DEC 25
Dividend Ex
23
DEC 25
Dividend Payment

Dividends

406.64%Dividend Yield
Dec 23
CL$622.72
Dec 22
CL$665.46
Dec 21
CL$345.94
Dec 20
CL$440.79
Dec 19
CL$356.19
10Y Growth
N/A
5Y Growth
13.32%
3Y Growth
24.37%
1Y Growth
6.86%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBH.SN. It's not an investment recommendation.
Alphabet
68145
GOOGL
Apple
60342
AAPL
Microsoft
56068
MSFT
Amazon
51638
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares Biotechnology
IBB
Mkt Cap7.41B
iShares Biotechnology ETF is a direct competitor, focusing on similar biotech and pharmaceutical companies, making it a prime alternative for investors interested in the biotech sector.
SPDR Biotech
XBI
Mkt Cap7.19B
SPDR S&P Biotech ETF tracks a biotechnology index, directly competing with BBH by offering exposure to biotech stocks, but with a different index methodology.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap1.12B
First Trust NYSE Arca Biotechnology Index Fund is another major competitor, targeting the biotech industry with a selection of companies that often overlaps with those in BBH's portfolio.
Virtus LifeSci Biotech Products
BBP
Mkt Cap20.68M
Virtus LifeSci Biotech Products ETF focuses specifically on biotech product companies, competing with BBH by targeting a similar niche within the biotech sector.
Virtus LifeSci Biotech Clinical Trials
BBC
Mkt Cap10.22M
Virtus LifeSci Biotech Clinical Trials ETF offers exposure to companies in clinical trials, presenting a more focused but still competitive angle to BBH's broader biotech scope.
Invesco Biotechnology & Genome
PBE
Mkt Cap257.31M
Invesco Dynamic Biotechnology & Genome ETF competes by investing in biotech and genome companies, offering a thematic investment similar to BBH but with a dynamic investment strategy.
Principal Healthcare Innovators
BTEC
Mkt Cap16.4M
Principal Healthcare Innovators Index ETF targets healthcare innovation, including biotech, making it a competitor by focusing on a cutting-edge segment of the market similar to BBH.
ALPS Medical Breakthroughs
SBIO
Mkt Cap104.11M
ALPS Medical Breakthroughs ETF is focused on small- and mid-cap biotech and pharmaceutical companies, offering a unique angle but still competing for the same investment dollars as BBH.
Global X Genomics & Biotechnology
GNOM
Mkt Cap95.21M
Global X Genomics & Biotechnology ETF competes by focusing on genomics and biotechnology, offering a niche within the biotech sector that overlaps with BBH's investment focus.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap135.25M
iShares Genomics Immunology and Healthcare ETF competes by investing in companies at the forefront of genomics and immunology, presenting a thematic overlap with BBH's biotech focus.

About

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Show more...
CEO
Country
US
ISIN
US92189F7261

Listings

XNAS
US
BBH
SN
CL
BBH.SN
SN
CL
BBHCL.SN